Sector ratings Evotec SE CBOE

Stocks

Market Closed - CBOE 11:30:00 2026-09-11 EDT			5-day change	1st Jan Change
3.217 ^EUR	0.00%		0.00%	-40.37%

09-09	Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment	MT
09-09	Evotec Commences Early-stage Study of Potential Orthopoxvirus Therapy	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	45.48B		AAA
REVOLUTION MEDICINES, INC.	43.68B	-	B	-	-
IQVIA HOLDINGS INC.	43.09B		AAA
BEONE MEDICINES AG	39.4B		-
CELLTRION, INC.	31.91B		A
ASCENDIS PHARMA A/S	17.31B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.4B		BBB
EUROFINS SCIENTIFIC SE	14.24B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.28B		AA
ICON PUBLIC LIMITED COMPANY	13.06B		AAA
BIO-TECHNE CORPORATION	11.31B		AA
TEMPUS AI, INC.	10.65B		A		-
ABIVAX	10.25B	-	BBB	-	-
PHARMARON BEIJING CO., LTD.	10.13B		AA
PROTAGONIST THERAPEUTICS, INC.	9.59B		BB		-
KYMERA THERAPEUTICS, INC.	9.56B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	9.34B	-	B	-	-
GENSCRIPT BIOTECH CORPORATION	9.02B		AA		-
IONIS PHARMACEUTICALS, INC.	9.01B	-	A	-	-
Average	19.3B		A
Weighted average by Cap.			A